Stryker Corporation $SYK Shares Acquired by Talbot Financial LLC

Talbot Financial LLC increased its stake in Stryker Corporation (NYSE:SYK) by 22.4% during the 2nd quarter, Holdings Channel.com reports. The fund owned 53,747 shares of the medical technology company’s stock after buying an additional 9,827 shares during the period. Stryker accounts for approximately 2.0% of Talbot Financial LLC’s portfolio, making the stock its 14th largest position. Talbot Financial LLC’s holdings in Stryker were worth $21,264,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Goodman Advisory Group LLC acquired a new position in shares of Stryker in the 1st quarter valued at about $32,000. City Holding Co. lifted its stake in shares of Stryker by 528.6% in the 1st quarter. City Holding Co. now owns 88 shares of the medical technology company’s stock valued at $33,000 after purchasing an additional 74 shares in the last quarter. Ridgewood Investments LLC lifted its stake in shares of Stryker by 48.4% in the 2nd quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock valued at $36,000 after purchasing an additional 30 shares in the last quarter. Ransom Advisory Ltd acquired a new position in shares of Stryker in the 1st quarter valued at about $37,000. Finally, Smallwood Wealth Investment Management LLC acquired a new position in shares of Stryker in the 1st quarter valued at about $40,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the transaction, the director directly owned 3,222,108 shares of the company’s stock, valued at $1,212,962,556.60. This represents a 5.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Viju Menon sold 500 shares of the business’s stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $390.61, for a total value of $195,305.00. Following the completion of the sale, the insider owned 12,511 shares of the company’s stock, valued at $4,886,921.71. This trade represents a 3.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 5.90% of the company’s stock.

Stryker Stock Performance

Shares of SYK opened at $370.59 on Friday. The business’s 50 day moving average is $382.81 and its two-hundred day moving average is $378.93. Stryker Corporation has a 52-week low of $329.16 and a 52-week high of $406.19. The firm has a market cap of $141.68 billion, a price-to-earnings ratio of 49.08, a PEG ratio of 2.67 and a beta of 0.94. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.07 by $0.06. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The company had revenue of $6.02 billion for the quarter, compared to analyst estimates of $5.92 billion. During the same period in the prior year, the company posted $2.81 EPS. Stryker’s quarterly revenue was up 11.1% on a year-over-year basis. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Analysts forecast that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 30th. Stryker’s dividend payout ratio is presently 44.50%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on SYK shares. Wall Street Zen lowered Stryker from a “buy” rating to a “hold” rating in a research note on Friday, September 26th. Redburn Partners set a $420.00 price objective on Stryker in a research note on Thursday, September 18th. Rothschild Redb raised Stryker to a “hold” rating in a research note on Thursday, September 18th. Weiss Ratings reissued a “buy (b-)” rating on shares of Stryker in a research report on Saturday, September 27th. Finally, Rothschild & Co Redburn assumed coverage on Stryker in a research report on Thursday, September 18th. They set a “neutral” rating and a $420.00 price target on the stock. Fifteen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $430.33.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.